Cancer

Cancer is the interdisciplinary oncology journal of the American Cancer Society, published by Wiley since 1948 and spanning the distance from laboratory discovery to bedside care, with a 2025 Journal Impact Factor of 5.6.《癌症》是（American Cancer Society）的跨学科肿瘤学期刊，由（Wiley）出版，1948 年创刊，覆盖从实验室发现到临床诊疗的完整链条，2025 年期刊影响因子为 5.6。

Scope

• The remit runs from the aetiology and course of human cancer through diagnosis and treatment to rehabilitation.收录范围从人类肿瘤的病因与病程，延伸至诊断、治疗与康复。
• The journal aims to transfer knowledge from the laboratory to the bedside and to contribute to prevention, early detection, diagnosis and cure.刊物力图把实验室知识推向临床床边，并在预防、早期发现、诊断与治愈各环节有所贡献。
• It publishes original research and review articles, and issues educational supplements aimed at a broad oncology audience.发表原创研究与综述，并出版面向广泛肿瘤学读者的教育增刊。
• Readership spans medical, surgical and radiation oncology, haematology, pathology, radiology, epidemiology and basic science.读者群覆盖肿瘤内科、外科与放射治疗、血液学、病理学、影像学、流行病学与基础研究。
• Section editors cover organ-specific disease areas including breast, chest and lung, gastrointestinal, genitourinary, gynaecologic, neuro-oncology, sarcoma and paediatric oncology.学科编辑按瘤种划分，包括乳腺、胸部与肺、胃肠、泌尿生殖、妇科、神经肿瘤、肉瘤与儿童肿瘤。
• Symptom control and palliative care, survivorship, disparities research and diagnostic imaging are organised as separate sections.症状控制与姑息治疗、生存者研究、健康差异研究与诊断影像，均单设栏目。
• Developmental therapeutics and clinical trials hold dedicated sections, reflecting the journal's clinical orientation.新药开发与临床试验设有专属栏目，体现刊物的临床取向。

History

• Cancer was established in 1948 as the journal of the American Cancer Society and is among the oldest peer-reviewed oncology titles.《癌症》于 1948 年作为（American Cancer Society）的期刊创办，是最早的同行评审肿瘤学期刊之一。
• Fred W. Stewart was the first editor-in-chief, serving from 1948 until 1961.（Fred W. Stewart）为首任主编，任期自 1948 年至 1961 年。
• Cancer Cytopathology appeared as a section of the journal from 1997 and was split off as a separate title in 2008.《癌症细胞病理学》自 1997 年起作为本刊的一个栏目存在，2008 年独立成刊。
• The journal has been published by Wiley, now Wiley-Blackwell, on behalf of the society throughout its modern history.在现代刊史中，本刊始终由（Wiley）及其后继的（Wiley-Blackwell）代表学会出版。
• Fadlo R. Khuri preceded the current editor-in-chief, and Suresh S. Ramalingam took over the post in the 2020s.现任主编之前为（Fadlo R. Khuri），（Suresh S. Ramalingam）于 2020 年代接任。
• The journal appears fortnightly, with volume 132 reaching at least 24 numbered issues in 2026, and the impact factor moved from 5.1 in 2024 to 5.6 in 2025.刊物为双周刊，2026 年第 132 卷至少出满 24 期；影响因子由 2024 年的 5.1 升至 2025 年的 5.6。

Editors

• Suresh S. Ramalingam, a thoracic oncologist at the Winship Cancer Institute of Emory University, is editor-in-chief.（Emory University）温希普癌症研究所的胸部肿瘤学家（Suresh S. Ramalingam）任主编。
• Ruth O'Regan of the University of Rochester is deputy editor and also leads the breast disease section.（University of Rochester）的（Ruth O'Regan）任副主编，并主持乳腺疾病栏目。
• Section editors include Courtney D. DiNardo and Ajay K. Nooka for haematologic malignancies, Daniel Morgensztern for chest and lung disease and Mitchell C. Posner for gastrointestinal disease.学科编辑包括负责血液肿瘤的（Courtney D. DiNardo）与（Ajay K. Nooka）、负责胸部与肺部疾病的（Daniel Morgensztern）以及负责胃肠疾病的（Mitchell C. Posner）。
• Saro H. Armenian leads outcomes research and survivorship at City of Hope, and Abby Rosenberg leads paediatric oncology across Dana-Farber and Boston Children's.（City of Hope）的（Saro H. Armenian）主持结局研究与生存者方向，（Abby Rosenberg）在（Dana-Farber）与（Boston Children's）主持儿童肿瘤栏目。
• Yan Xu of Peking Union Medical College Hospital serves as regional editor for Asia and the Pacific.（Peking Union Medical College Hospital）的（Yan Xu）担任亚太区域编辑。
• Statistical reviewers from Emory, Johns Hopkins and Cedars-Sinai support methodological review, and open access is offered through the Wiley OnlineOpen programme.来自（Emory）、（Johns Hopkins）与（Cedars-Sinai）的统计学审稿人承担方法学把关；开放获取通过（Wiley OnlineOpen）计划提供。